Bioventus Inc.
BVS
$7.45
-$0.15-1.97%
NASDAQ
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 118.70% | 98.87% | -53.12% | 77.03% | 77.02% |
| Total Depreciation and Amortization | -9.28% | -11.88% | -13.19% | -28.66% | -47.63% |
| Total Amortization of Deferred Charges | -16.67% | -16.67% | -16.67% | -16.67% | 50.46% |
| Total Other Non-Cash Items | -11.43% | -9.82% | 140.55% | -56.28% | -63.96% |
| Change in Net Operating Assets | -187.84% | -41.95% | -8.52% | -270.32% | -390.78% |
| Cash from Operations | 87.71% | 223.15% | 271.86% | 152.83% | 192.22% |
| Capital Expenditure | -219.10% | 22.57% | 62.35% | 86.34% | 92.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 10,907.21% | 10,907.21% | -28.83% | -28.83% | -100.64% |
| Other Investing Activities | 100.00% | 100.00% | 100.00% | 93.84% | 93.84% |
| Cash from Investing | 1,337.64% | 689.77% | -22.55% | 45.27% | -113.33% |
| Total Debt Issued | -- | 0.00% | 0.00% | -- | -100.00% |
| Total Debt Repaid | -549.88% | -218.03% | 12.50% | 31.72% | 87.93% |
| Issuance of Common Stock | 78.09% | 132.89% | 177.27% | 213.88% | -12.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,208.25% | -748.81% | -37.95% | 161.48% | 52.17% |
| Cash from Financing | -552.08% | -1,351.68% | 15.24% | -104.78% | 63.40% |
| Foreign Exchange rate Adjustments | -1,314.73% | 6.76% | -321.81% | -507.00% | -109.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.60% | -64.84% | 89.19% | -9.93% | 315.05% |